← All stocks

Whitehawk Therapeutics, Inc.

WHWK Net buying
CIK 0001422142 #3692 in the set updated 21 Sep 2026
Bought (120 mo)
$57.56M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$7.48M
$73.27K on a plan · $41.94K straight out of an exercise
Sold at will
$7.36M
82 of 84 sales
Net
+$50.08M
+$50.20M against sales at will

By person

21 insiders · 132 transactions
3.4×

David Lennon holds only 3.4 times base salary in stock. $2.35M of shares against $676.50K in salary for 2025.

Salary from the company's own proxy. The shares are what David Lennon last reported holding, valued at $4.13, the price Common Stock was last bought or sold at on the open market here, on 16 Apr 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Dalal Anupam
Director
$20.00M (1)
+$20.00M
4,702,871
$19.42M
+207,166%
Satter Muneer A
Director
$13.79M (33)
+$13.79M
5,621,835
$23.22M
+165.0%
Khuong Chau Quang
Director
$6.81M (2)
+$6.81M
5,193,946
$21.45M
+42.2%
ORBIMED ADVISORS LLC entity
10% owner
$6.81M (2)
$41.94K (1) scheduled
+$6.77M
5,193,946
$21.45M
+42.2%
Castelein Caley
Director
$5.40M (2)
+$5.40M
2,440,794
$10.08M
+160.0%
Desai Neil
Director
$3.01M (44)
−$3.01M
1,171,543
$4.84M
−39.0%
WEISS PAUL M
Director
$1.36M (1)
+$1.36M
1,576,167
$6.51M
+20.9%
Lennon David James
CHIEF EXECUTIVE OFFICER
$1.09M (8)
−$1.09M
569,643
$2.35M
Novartis Bioventures Ltd entity
10% owner
$2.80M (1)
$1.79M (21)
+$1.01M
4,049,804
$16.73M
−22.8%
Giacobello Scott M.
CHIEF FINANCIAL OFFICER
$897.21K (4)
−$897.21K
333,489
$1.38M
+2,721%
BALL BRYAN
See remarks
$640.10K (6)
−$640.10K
448,126
$1.85M
+348.1%
Gardner Joseph H.
President
$508.54K (3)
+$508.54K
603,019
$2.49M
+22.3%
HOFFMAN STEPHEN J
Chief Executive Officer
$64.14K (2)
+$64.14K
31,967
$132.02K
PETERS KEVIN G.
See Remarks
$18.21K (1)
+$18.21K
320,536
$1.32M
+1.1%
Aghazadeh Behzad
Director
3,471,752
$14.34M
+1,057%
Zhao Baiteng
Director
1,250,000
$5.16M
Prelack Steven
Director
24,485
$101.12K
Delaney Brendan
See remarks
20,000
$82.60K
Dugan Margaret
Chief Medical Officer
19,132
$79.02K
Cohen Cheryl
Director
16,160
$66.74K
Dugel Pravin
Director
12,568
$51.91K

No percentages here. This company's share count has moved by a factor of 2.3 over the window, from 24,647,392 to 57,009,010 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 217
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 1
Sales at will 82
Transactions with no price 0
Shares from compensation/vesting 13,720,945
Sales filed before the plan box existed 22
History held since 17 Mar 2017